Skip to main content
ENTX logo
ENTX
(NASDAQ)
Entera Bio Ltd.
$1.26-- (--)
Loading... - Market loading

Entera Bio (ENTX) Stock Price & Financial Analysis

Entera Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.17 - $1.39
52-Week High$3.22
52-Week Low$0.91
Open$1.19
Volume739.59K
Average Volume (3M)739.59K
Market Cap59.33M
Shares Outstanding47.09M
Price to Sales (P/S)432.92
Price to Book (P/B)3.52
EV/EBITDA-4.20
Revenue (TTM)124.00K
Net Income (TTM)-10.78M
Free Cash Flow (TTM)-7.09M
EPS (TTM)$-0.23
Profit Margin-8694.35%
Operating Margin-8729.03%
Return on Equity (ROE)-70.77%
Debt to Equity0.01
50-Day MA$1.35
200-Day MA$1.90
52-Week Change-30.06%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Entera Bio

What is the current stock price for ENTX?

As of the latest trading session, ENTX stock trades at $1.26. The 52-week range is $0.91–$3.22, with a day range of $1.17–$1.39.

What is the P/E ratio for ENTX?

The P/E ratio (Price-to-Earnings) for ENTX is shown in the Key Statistics section. This valuation metric helps compare Entera Bio Ltd. to industry peers.

Does ENTX pay dividends?

Entera Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ENTX?

Based on 1 analyst, the consensus for ENTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ENTX?

Entera Bio's market capitalization is $59.3M, classifying it as a micro-cap company. Entera Bio operates in the Healthcare sector within the Biotechnology industry.